Novo Nordisk has invested 6.4bn Brazilian reais ($1.09bn) to expand its facility in Brazil as the company ramps up efforts to ...

According to Kiran Jones, a clinical pharmacist at Oxford Online Pharmacy, some of the most concerning side effects of GLP-1 ...

As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming less ...

GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic ...

As the obesity rate among people with type 1 diabetes rises, patients are taking popular weight loss drugs like Ozempic—and ...

Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...

Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...

India is home to the second-largest number of diabetics globally, with a prevalence rate of around 12 per cent ...

Attendees of the Academy of Managed Care Pharmacy annual meeting share explain what draws them to the conference year after year.

As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming less ...